CTKB — Cytek Biosciences Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Cytek Biosciences Inc (CTKB), worth $3.08M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $2.93M | 0.00% | -2.3% |
| Quadrature | $94.89K | 0.00% | NEW |
| Caxton Associates | $52.85K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.